Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Fupin Hu"'
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT Colistin is used as a last-line therapy against carbapenem-resistant Klebsiella pneumoniae (CRKP). However, colistin resistance in Klebsiella pneumoniae is increasingly reported worldwide. This study aims to investigate the instrumental role
Externí odkaz:
https://doaj.org/article/bb6c6a616ff9458585a18413c69c8072
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Objective Healthcare-associated Gram-negative bacterial meningitis is a substantial clinical issue with poor outcomes, especially for neurosurgical patients. Here, we aimed to study the characteristics and treatment options of patients with
Externí odkaz:
https://doaj.org/article/e9157e1372c945e9a9beae0c77e29c63
Autor:
Rina Bai, Xiao Wang, Zhiyu Zou, Wenjing Zhou, Chang Tan, Yue Cao, Bo Fu, Weishuai Zhai, Fupin Hu, Yang Wang, Congming Wu, Yuanqi Zhu, Chengtao Sun
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Despite no carbapenem use in food animals, carbapenem-resistant Klebsiella pneumoniae (CRKP) perseveres within food animals, rising significant concerns regarding public health risks originating from these non-clinical reservoirs. To investigate the
Externí odkaz:
https://doaj.org/article/d4283a2c644a4ea2bfdb9b0751349d54
Autor:
Qingyu Shi, Siquan Shen, Chengkang Tang, Li Ding, Yan Guo, Yang Yang, Shi Wu, Renru Han, Dandan Yin, Fupin Hu
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Ceftazidime-avibactam resistance attributable to the blaKPC-2 gene mutation is increasingly documented in clinical settings. In this study, we characterized the mechanisms leading to the development of ceftazidime-avibactam resistance in ST11-K47 hyp
Externí odkaz:
https://doaj.org/article/6912819c762c49e2959da541d64b54e7
Autor:
Siquan Shen, Chengkang Tang, Weiwei Yang, Li Ding, Renru Han, Qingyu Shi, Yan Guo, Dandan Yin, Fupin Hu
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Ceftazidime-avibactam (CZA) is employed for the treatment of infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP). Resistance to CZA is frequently linked to point mutations in the blaKPC. We conducted in vitro sim
Externí odkaz:
https://doaj.org/article/e3e101210cdd45f1b52cd05f7cad48e5
Autor:
Bo Fu, Jian Xu, Dandan Yin, Chengtao Sun, Dejun Liu, Weishuai Zhai, Rina Bai, Yue Cao, Qin Zhang, Shizhen Ma, Timothy R. Walsh, Fupin Hu, Yang Wang, Congming Wu, Jianzhong Shen
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTDespite carbapenems not being used in animals, carbapenem-resistant Enterobacterales (CRE), particularly New Delhi metallo-β-lactamase-producing CRE (NDM-CRE), are prevalent in livestock. Concurrently, the incidence of human infections cause
Externí odkaz:
https://doaj.org/article/a141bb1d016f458994a2d9acbb3f7ea2
Autor:
Mei Zeng, Jun Xia, Zhiyong Zong, Yi Shi, Yuxing Ni, Fupin Hu, Yijian Chen, Chao Zhuo, Bijie Hu, Xiaoju Lv, Jiabin Li, Zhengyin Liu, Jing Zhang, Wenjie Yang, Fan Yang, Qiwen Yang, Hua Zhou, Xin Li, Jianhua Wang, Yimin Li, Jian'an Ren, Baiyi Chen, Dechang Chen, Anhua Wu, Xiangdong Guan, Jieming Qu, Depei Wu, Xiaojun Huang, Haibo Qiu, Yingchun Xu, Yunsong Yu, Minggui Wang
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 4, Pp 653-671 (2023)
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug-resistant, resulting in limited antimicrobial treatment options and high mortali
Externí odkaz:
https://doaj.org/article/086fe2a85e514e3581f1906b212d7263
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT The aim of this study was to evaluate the correlation between inhibitory zones and minimum inhibitory concentrations (MICs) when testing cefiderocol against Acinetobacter baumannii complex using disk diffusion and the broth microdilution (BM
Externí odkaz:
https://doaj.org/article/da096118659e4b0595a580838047bfc4
Autor:
Xiangning Huang, Siquan Shen, Fan Chang, Xin Liu, Jinxi Yue, Ning Xie, Lin Yin, Fupin Hu, Daiwen Xiao
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 5 (2023)
ABSTRACT The emergence of various new Klebsiella pneumoniae carbapenemase (KPC) variants leading to ceftazidime-avibactam treatment failure is a new challenge in current clinical anti-infection treatment. Here, we report a ceftazidime-avibactam-resis
Externí odkaz:
https://doaj.org/article/4f66e99650514557b73a08b3f26735bb
Publikováno v:
BMC Microbiology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Ceftobiprole is a fifth-generation cephalosporin which has been reported to have broad antibacterial spectrum when tested against bacteria collected from other countries except China. This study evaluated the in vitro activity of
Externí odkaz:
https://doaj.org/article/9fbae673a36f47d78c7f6e727e6f2664